737 related articles for article (PubMed ID: 27479696)
1. Acetylation control of cardiac fatty acid β-oxidation and energy metabolism in obesity, diabetes, and heart failure.
Fukushima A; Lopaschuk GD
Biochim Biophys Acta; 2016 Dec; 1862(12):2211-2220. PubMed ID: 27479696
[TBL] [Abstract][Full Text] [Related]
2. Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes.
Fukushima A; Lopaschuk GD
Biochim Biophys Acta; 2016 Oct; 1861(10):1525-34. PubMed ID: 26996746
[TBL] [Abstract][Full Text] [Related]
3. Role of CoA and acetyl-CoA in regulating cardiac fatty acid and glucose oxidation.
Abo Alrob O; Lopaschuk GD
Biochem Soc Trans; 2014 Aug; 42(4):1043-51. PubMed ID: 25110000
[TBL] [Abstract][Full Text] [Related]
4. Cardiac Energy Metabolism in Heart Failure.
Lopaschuk GD; Karwi QG; Tian R; Wende AR; Abel ED
Circ Res; 2021 May; 128(10):1487-1513. PubMed ID: 33983836
[TBL] [Abstract][Full Text] [Related]
5. Myocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets.
Fukushima A; Milner K; Gupta A; Lopaschuk GD
Curr Pharm Des; 2015; 21(25):3654-64. PubMed ID: 26166604
[TBL] [Abstract][Full Text] [Related]
6. Acetylation of mitochondrial proteins by GCN5L1 promotes enhanced fatty acid oxidation in the heart.
Thapa D; Zhang M; Manning JR; Guimarães DA; Stoner MW; O'Doherty RM; Shiva S; Scott I
Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H265-H274. PubMed ID: 28526709
[TBL] [Abstract][Full Text] [Related]
7. Obesity-induced lysine acetylation increases cardiac fatty acid oxidation and impairs insulin signalling.
Alrob OA; Sankaralingam S; Ma C; Wagg CS; Fillmore N; Jaswal JS; Sack MN; Lehner R; Gupta MP; Michelakis ED; Padwal RS; Johnstone DE; Sharma AM; Lopaschuk GD
Cardiovasc Res; 2014 Sep; 103(4):485-97. PubMed ID: 24966184
[TBL] [Abstract][Full Text] [Related]
8. Protein acetylation in skeletal muscle mitochondria is involved in impaired fatty acid oxidation and exercise intolerance in heart failure.
Tsuda M; Fukushima A; Matsumoto J; Takada S; Kakutani N; Nambu H; Yamanashi K; Furihata T; Yokota T; Okita K; Kinugawa S; Anzai T
J Cachexia Sarcopenia Muscle; 2018 Oct; 9(5):844-859. PubMed ID: 30168279
[TBL] [Abstract][Full Text] [Related]
9. Acetylation and succinylation contribute to maturational alterations in energy metabolism in the newborn heart.
Fukushima A; Alrob OA; Zhang L; Wagg CS; Altamimi T; Rawat S; Rebeyka IM; Kantor PF; Lopaschuk GD
Am J Physiol Heart Circ Physiol; 2016 Aug; 311(2):H347-63. PubMed ID: 27261364
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of cardiac pathology in diabetes - Experimental insights.
Varma U; Koutsifeli P; Benson VL; Mellor KM; Delbridge LMD
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1949-1959. PubMed ID: 29109032
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial complex I defect and increased fatty acid oxidation enhance protein lysine acetylation in the diabetic heart.
Vazquez EJ; Berthiaume JM; Kamath V; Achike O; Buchanan E; Montano MM; Chandler MP; Miyagi M; Rosca MG
Cardiovasc Res; 2015 Sep; 107(4):453-65. PubMed ID: 26101264
[TBL] [Abstract][Full Text] [Related]
12. Branched chain amino acid metabolic reprogramming in heart failure.
Sun H; Wang Y
Biochim Biophys Acta; 2016 Dec; 1862(12):2270-2275. PubMed ID: 27639835
[TBL] [Abstract][Full Text] [Related]
13. Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure.
Mori J; Zhang L; Oudit GY; Lopaschuk GD
J Mol Cell Cardiol; 2013 Oct; 63():98-106. PubMed ID: 23886814
[TBL] [Abstract][Full Text] [Related]
14. Exogenous H
Sun Y; Tian Z; Liu N; Zhang L; Gao Z; Sun X; Yu M; Wu J; Yang F; Zhao Y; Ren H; Chen H; Zhao D; Wang Y; Dong S; Xu C; Lu F; Zhang W
J Mol Med (Berl); 2018 Apr; 96(3-4):281-299. PubMed ID: 29349500
[TBL] [Abstract][Full Text] [Related]
15. Targeting fatty acid metabolism in heart failure: is it a suitable therapeutic approach?
Arumugam S; Sreedhar R; Thandavarayan RA; Karuppagounder V; Watanabe K
Drug Discov Today; 2016 Jun; 21(6):1003-8. PubMed ID: 26905600
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial protein acetylation is driven by acetyl-CoA from fatty acid oxidation.
Pougovkina O; te Brinke H; Ofman R; van Cruchten AG; Kulik W; Wanders RJ; Houten SM; de Boer VC
Hum Mol Genet; 2014 Jul; 23(13):3513-22. PubMed ID: 24516071
[TBL] [Abstract][Full Text] [Related]
17. Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart.
Jaswal JS; Keung W; Wang W; Ussher JR; Lopaschuk GD
Biochim Biophys Acta; 2011 Jul; 1813(7):1333-50. PubMed ID: 21256164
[TBL] [Abstract][Full Text] [Related]
18. Weight loss enhances cardiac energy metabolism and function in heart failure associated with obesity.
Karwi QG; Zhang L; Altamimi TR; Wagg CS; Patel V; Uddin GM; Joerg AR; Padwal RS; Johnstone DE; Sharma A; Oudit GY; Lopaschuk GD
Diabetes Obes Metab; 2019 Aug; 21(8):1944-1955. PubMed ID: 31050157
[TBL] [Abstract][Full Text] [Related]
19. Methylene blue decreases mitochondrial lysine acetylation in the diabetic heart.
Berthiaume JM; Hsiung CH; Austin AB; McBrayer SP; Depuydt MM; Chandler MP; Miyagi M; Rosca MG
Mol Cell Biochem; 2017 Aug; 432(1-2):7-24. PubMed ID: 28303408
[TBL] [Abstract][Full Text] [Related]
20. Cardiac mitochondrial energy metabolism in heart failure: Role of cardiolipin and sirtuins.
Dolinsky VW; Cole LK; Sparagna GC; Hatch GM
Biochim Biophys Acta; 2016 Oct; 1861(10):1544-54. PubMed ID: 26972373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
